Skip to content

Author

Kinga Skalniak

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Asymptomatic Microhematuria in Adults: Risk-Stratified Evaluation, Diagnostic Yield and Strategies to Avoid Unnecessary Testing

Introduction and Purpose. Asymptomatic microhematuria is a common finding in adults, but the probability of clinically significant genitourinary malignancy varies considerably between patients. This review evaluates current approaches to microhematuria, focusing on risk stratification, diagnostic yield, and strategies...

Julia Wojtanowicz, Kinga Skalniak, M. Bochnak · 0 citations
Review Open access Sep 2026

Hepatocellular Carcinoma in the Twenty-First Century: Risk-Adapted Surveillance, Biomarkers, and Evolving Therapeutic Strategies

Introduction and Purpose The increasing contribution of metabolic dysfunction-associated steatotic liver disease (MASLD) to hepatocellular carcinoma (HCC) has highlighted important limitations of conventional ultrasound-based surveillance. Obesity, hepatic steatosis, and heterogeneous liver parenchyma may impair visua...

M. Bochnak, Kinga Skalniak, Julia Wojtanowicz · 0 citations
Review

QUALITY IN

Risk-stratified evaluation can reduce unnecessary testing while maintaining more intensive assessment for patients with a meaningful probability of malignancy, and further refinement of risk models and prospective validation of biomarker-guided pathways may allow more individualized diagnostic strategies.

Julia Wojtanowicz, Kinga Skalniak, M. Bochnak · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.